The novel therapy of this peptide represents a exciting advance in the care of the condition. Unlike existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – https://tirzepatidepeptide306682.idblogmaker.com/40709210/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment